Clinical Trial: Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Combined Retinoic Acid,Arsenic Trioxide and Chemotherapy for Newly-diagnosed Acute Promyelocytic Leukemia: Chinese National Multi-center Randomized Study

Brief Summary: In this prospective randomized study for patients with newly diagnosed acute promyelocytic leukemia, patients will be randomized into two groups which received retinoic acid and arsenic trioxide based treatment versus retinoic acid and chemotherapy based regimen.